Our results demonstrated that MMP-9 and uPA activities in 4T1 cells were reduced when treated with RA-XII for at least 48 hours, suggesting that RA-XII is able to inhibit ECM degradation and hence cancer cell invasion. The gene discussed is PLAU; the disease is cancer.